Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Briggs

Showing results (121-130 of 229) with videos related to

Pageof 23
Sort By:
Oncology and Therapy|July 24, 2020
Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed SettingWalter Bouwmeester, Andrew Briggs, Ben van Hout, et al.
Plos One|October 27, 2016
The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011Janet Bouttell, James Lewsey, Claudia Geue, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case StudyAndrew Briggs, Beth Wehler, Jennifer G Gaultney, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 14, 2019
Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH studyVictoria Federico Paly, Ian Naya, Necdet B Gunsoy, et al.
Health Economics|March 5, 2014
Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makersBjörn Stollenwerk, Stefan K Lhachimi, Andrew Briggs, et al.
Annals of Surgical Oncology|June 10, 2020
Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and CostYinin Hu, Andrew Briggs, Renee L Gennarelli, et al.
BMJ Global Health|February 21, 2022
Implementing care for healthy ageingMatteo Cesari, Yuka Sumi, Zee A Han, et al.
Journal of Medical Economics|July 30, 2016
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in ScotlandChristopher Parker, Beth Woods, James Eaton, et al.
BMJ Open|September 3, 2013
How effective is the Forestry Commission Scotland's woodland improvement programme--'Woods In and Around Towns' (WIAT)--at improving psychological well-being in deprived urban communities? A quasi-experimental studyEva Silveirinha de Oliveira, Peter Aspinall, Andrew Briggs, et al.
BMJ Open|July 16, 2020
Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart reviewRoman Hájek, Sebastian Gonzalez-McQuire, Zsolt Szabo, et al.
Pageof 23

Showing results (121-130 of 229) with videos related to

Sort By:
Pageof 23
Oncology and Therapy|July 24, 2020
Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed SettingWalter Bouwmeester, Andrew Briggs, Ben van Hout, et al.
Plos One|October 27, 2016
The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011Janet Bouttell, James Lewsey, Claudia Geue, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case StudyAndrew Briggs, Beth Wehler, Jennifer G Gaultney, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 14, 2019
Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH studyVictoria Federico Paly, Ian Naya, Necdet B Gunsoy, et al.
Health Economics|March 5, 2014
Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makersBjörn Stollenwerk, Stefan K Lhachimi, Andrew Briggs, et al.
Annals of Surgical Oncology|June 10, 2020
Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and CostYinin Hu, Andrew Briggs, Renee L Gennarelli, et al.
BMJ Global Health|February 21, 2022
Implementing care for healthy ageingMatteo Cesari, Yuka Sumi, Zee A Han, et al.
Journal of Medical Economics|July 30, 2016
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in ScotlandChristopher Parker, Beth Woods, James Eaton, et al.
BMJ Open|September 3, 2013
How effective is the Forestry Commission Scotland's woodland improvement programme--'Woods In and Around Towns' (WIAT)--at improving psychological well-being in deprived urban communities? A quasi-experimental studyEva Silveirinha de Oliveira, Peter Aspinall, Andrew Briggs, et al.
BMJ Open|July 16, 2020
Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart reviewRoman Hájek, Sebastian Gonzalez-McQuire, Zsolt Szabo, et al.
Pageof 23